Holen Sie sich die Stockscreener-App
2.78
1.09%
0.03
Handel nachbörslich:
2.55
-0.23
-8.27%
Schlusskurs vom Vortag:
$2.75
Offen:
$2.7
24-Stunden-Volumen:
67,625
Relative Volume:
0.04
Marktkapitalisierung:
$1.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.00M
KGV:
-2.4174
EPS:
-1.15
Netto-Cashflow:
$-3.85M
1W Leistung:
-3.47%
1M Leistung:
-24.66%
6M Leistung:
-27.77%
1J Leistung:
-72.20%
1-Tages-Spanne:
$2.66
$2.8062
1-Wochen-Bereich:
$2.60
$2.9392
52-Wochen-Spanne:
$2.35
$15.54
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Firmenname
Protagenic Therapeutics Inc
Sektor
Branche
Telefon
(212) 994-8200
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie PTIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.78 | 2.39M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
Protagenic Therapeutics restructures operations, changes fiscal year, and reduces workforce - Investing.com
Protagenic Therapeutics Restructures to Focus on PT00114 - TipRanks
Protagenic Therapeutics approves restructuring plan on August 8SEC filing - MarketScreener
Protagenic (PTIXW) to cut ~$8M annually, shifts to virtual model - Stock Titan
Is Protagenic Therapeutics Inc. meeting your algorithmic filter criteriaGlobal Markets & Consistent Profit Trading Strategies - Newser
How hedge fund analytics apply to Protagenic Therapeutics Inc. Equity Warrant stockJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Sentiment analysis tools applied to Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Update & Fast Entry High Yield Tips - Newser
Is Protagenic Therapeutics Inc. Equity Warrant forming a bottoming baseJuly 2025 Retail & Weekly Momentum Picks - Newser
Protagenic Therapeutics Inc. Equity Warrant stock outlook for YEARJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-08-13 04:40:19 - Newser
How to escape a deep drawdown in Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Movers & Safe Capital Investment Plans - Newser
Analyzing drawdowns of Protagenic Therapeutics Inc. Equity Warrant with statistical tools2025 Key Highlights & Detailed Earnings Play Strategies - Newser
How to read the order book for Protagenic Therapeutics Inc.2025 Top Gainers & Consistent Profit Alerts - Newser
Visualizing Protagenic Therapeutics Inc. stock with heatmapsJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
How to use Fibonacci retracement on Protagenic Therapeutics Inc.2025 Risk Factors & Daily Profit Maximizing Tips - Newser
What makes Protagenic Therapeutics Inc. stock price move sharplyJuly 2025 Fed Impact & High Conviction Investment Ideas - Newser
What’s the profit margin of Protagenic Therapeutics Inc.Short-Term Capital Expansion - thegnnews.com
What makes Protagenic Therapeutics Inc. Equity Warrant stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
Is it too late to sell Protagenic Therapeutics Inc. Equity WarrantFree Low Volatility Stable Growth Picks - Newser
Can volume confirm reversal in Protagenic Therapeutics Inc.Safe Entry Strategy with High Win Rate - Newser
Protagenic Therapeutics Inc. stock outlook for YEARMomentum Trend Signal Weekly Recap Summary - Newser
Exit strategy if you’re trapped in Protagenic Therapeutics Inc.Investment Timing Strategy with Market Filters - Newser
Why Protagenic Therapeutics Inc. stock is on top investor watchlistsDay Trading Setup Forecast with Trend Model - Newser
Why Protagenic Therapeutics Inc. Equity Warrant stock attracts strong analyst attentionChart Risk Profile for Capital Preservation - Newser
Chart based analysis of Protagenic Therapeutics Inc. Equity Warrant trends - Newser
Protagenic Therapeutics Inc. Equity Warrant stock trend forecastFree Low Risk Buy Zone Opportunity Watch - Newser
Analyzing net buyer seller activity in Protagenic Therapeutics Inc. Equity WarrantStrong Buy Opportunity with Volume Support - Newser
Protagenic Therapeutics Inc. stock retracement – recovery analysisFree Consistent Profit Pattern Recognition Tools - Newser
Understanding Protagenic Therapeutics Inc.’s price movementPredictable Income Summary for Long-Term Trades - Newser
Key metrics from Protagenic Therapeutics Inc.’s quarterly dataFree Trade Setups With AI Powered Filters - Newser
How to integrate Protagenic Therapeutics Inc. Equity Warrant into portfolio analysis toolsConsistent Gain Plan with AI Support - Newser
Key resistance and support levels for Protagenic Therapeutics Inc. Equity WarrantIntraday Strategy with Real Time Monitoring - Newser
Earnings visualization tools for Protagenic Therapeutics Inc. Equity WarrantChart Signal and Short-Term Forecast Tracker - Newser
Is Protagenic Therapeutics Inc. Stock a Good Fit for Conservative InvestorsOversold Reversal Picks with Buy Zone - Newser
Why Protagenic Therapeutics Inc. stock attracts strong analyst attentionOversold Opportunity Scanner with RSI Data - Newser
Strategies to average down on Protagenic Therapeutics Inc.Trend Following Ideas with Volume Confirmation - Newser
Smart tools for monitoring Protagenic Therapeutics Inc.’s price actionLow Risk Trade Timing with Analysis Metrics - Newser
Volume spikes in Protagenic Therapeutics Inc. Equity Warrant stock – what they meanLow Drawdown Picks with Weekly Updates - Newser
Advanced analytics toolkit walkthrough for Protagenic Therapeutics Inc. Equity WarrantMulti-Bagger Detection with Trend Tools - Newser
Volatility clustering patterns for Protagenic Therapeutics Inc. Equity WarrantCommunity Picked Stocks with Trade Insights - Newser
Ranking Protagenic Therapeutics Inc. among high performing stocks via toolsFree AI Powered High Return Stock Calls - Newser
How to track smart money flows in Protagenic Therapeutics Inc.Trend Analysis for Safer Market Entries - Newser
Competitive Positioning of Protagenic Therapeutics Inc.: Is It Leading or LaggingEarnings Impact and Stock Reaction Analysis - Newser
Ranking Protagenic Therapeutics Inc. Equity Warrant among high performing stocks via toolsDaily Pick Forecast with Entry Zones - Newser
How strong is Protagenic Therapeutics Inc. Equity Warrant company’s balance sheetDiscover stocks with superior performance - Jammu Links News
Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):